PROCESSES FOR THE PREPARATION OF INTERMEDIATES OF RALTEGRAVIR
The present disclosure provides a process for the preparation of 2-(2-amino propan-2-y1)-N-(4-fluorobenzyl)-5-hy-droxy-1-methyl-6-oxo-1,6-dihydro-pyrimidine- 4-carboxamide by debenzylation of benzyl(2- {4-[(4-fluorobenzyl)carbamoy1]-5- hy-droxy- 1 -methy1-6-oxo-1,6-dihydropyrimidin-2-yllpropan-2-yl)...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
02.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides a process for the preparation of 2-(2-amino propan-2-y1)-N-(4-fluorobenzyl)-5-hy-droxy-1-methyl-6-oxo-1,6-dihydro-pyrimidine- 4-carboxamide by debenzylation of benzyl(2- {4-[(4-fluorobenzyl)carbamoy1]-5- hy-droxy- 1 -methy1-6-oxo-1,6-dihydropyrimidin-2-yllpropan-2-yl)carbamate. This process may be used in the synthesis of raltegravir and pharmaceutically acceptable salts thereof.
La présente invention concerne un procédé pour la préparation de 2-(2-amino propan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-méthyl-6-oxo-1,6-dihydro-pyrimidine-4-carboxamide par débenzylation de benzyl(2-{4-[(4-fluorobenzyl)carbamoyle]-5-hydroxy-1-méthyl-6-oxo-1,6-dihydropyrimidin-2-yl}propan-2-yl)carbamate. Ce procédé peut être utilisé dans la synthèse de raltégravir et de ses sels pharmaceutiquement acceptables. |
---|---|
Bibliography: | Application Number: CA20152938387 |